The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 38,242 | 627,019 | SH | SOLE | 627,019 | 0 | 0 | ||
AbbVie Inc. | Common | 00287Y109 | 47,590 | 513,658 | SH | SOLE | 513,658 | 0 | 0 | ||
AC Immune SA | Shares | H00263105 | 1,598 | 171,813 | SH | SOLE | 171,813 | 0 | 0 | ||
Acadia Healthcare Company, Inc. | Common | 00404A109 | 11,144 | 272,400 | SH | SOLE | 272,400 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 1,431 | 93,689 | SH | SOLE | 93,689 | 0 | 0 | ||
Acceleron Pharma Inc. | Common | 00434H108 | 8,286 | 170,766 | SH | SOLE | 170,766 | 0 | 0 | ||
Achillion Pharmaceuticals, Inc. | Common | 00448Q201 | 1,743 | 616,000 | SH | SOLE | 616,000 | 0 | 0 | ||
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 10,154 | 855,468 | SH | SOLE | 855,468 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | Note 2.00% 8/15/19 | 00767EAB8 | 8,436 | 13,000,000 | PRN | SOLE | 13,000,000 | 0 | 0 | ||
Aerpio Pharmaceuticals, Inc. | Common | 00810B105 | 3,175 | 765,000 | SH | SOLE | 765,000 | 0 | 0 | ||
Aetna Inc. | Common | 00817Y108 | 17,822 | 97,122 | SH | SOLE | 97,122 | 0 | 0 | ||
Affimed N.V. | Common | N01045108 | 2,681 | 1,624,792 | SH | SOLE | 1,624,792 | 0 | 0 | ||
Agios Pharmaceuticals, Inc. | Common | 00847X104 | 237 | 2,810 | SH | SOLE | 2,810 | 0 | 0 | ||
Akebia Therapeutics, Inc. | Common | 00972D105 | 2,661 | 266,612 | SH | SOLE | 266,612 | 0 | 0 | ||
Albireo Pharma, Inc. | Common | 01345P106 | 4,438 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 54,429 | 438,416 | SH | SOLE | 438,416 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 7,040 | 171,042 | SH | SOLE | 171,042 | 0 | 0 | ||
Allergan plc | Shares | G0177J108 | 41,486 | 248,836 | SH | SOLE | 248,836 | 0 | 0 | ||
Alliqua BioMedical, Inc. | Common | 019621309 | 338 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 12,841 | 130,376 | SH | SOLE | 130,376 | 0 | 0 | ||
Amarin Corporation plc | Sponsored ADR | 023111206 | 1,477 | 478,149 | SH | SOLE | 478,149 | 0 | 0 | ||
AmerisourceBergen Corporation | Common | 03073E105 | 7,905 | 92,707 | SH | SOLE | 92,707 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 129,322 | 700,588 | SH | SOLE | 700,588 | 0 | 0 | ||
Amicus Therapeutics, Inc. | Common | 03152W109 | 13,672 | 875,304 | SH | SOLE | 875,304 | 0 | 0 | ||
Anthem, Inc. | Common | 036752103 | 26,334 | 110,633 | SH | SOLE | 110,633 | 0 | 0 | ||
ARCA biopharma, Inc. | Common | 00211Y407 | 451 | 811,227 | SH | SOLE | 811,227 | 0 | 0 | ||
Ardelyx, Inc. | Common | 039697107 | 2,366 | 639,370 | SH | SOLE | 639,370 | 0 | 0 | ||
Arena Pharmaceuticals, Inc. | Common | 040047607 | 4,088 | 93,767 | SH | SOLE | 93,767 | 0 | 0 | ||
argenx SE | Sponsored ADR | 04016X101 | 3,226 | 38,931 | SH | SOLE | 38,931 | 0 | 0 | ||
Array BioPharma Inc. | Common | 04269X105 | 4,297 | 256,056 | SH | SOLE | 256,056 | 0 | 0 | ||
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 2,921 | 43,914 | SH | SOLE | 43,914 | 0 | 0 | ||
AstraZeneca PLC | Sponsored ADR | 046353108 | 27,347 | 778,888 | SH | SOLE | 778,888 | 0 | 0 | ||
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 4,993 | 814,588 | SH | SOLE | 814,588 | 0 | 0 | ||
Bausch Health Companies Inc. | Common | 91911K102 | 4,462 | 192,000 | SH | SOLE | 192,000 | 0 | 0 | ||
Baxter International Inc. | Sponsored ADR | 071813109 | 9,904 | 134,124 | SH | SOLE | 134,124 | 0 | 0 | ||
Becton, Dickinson and Company | Common | 075887109 | 12,691 | 52,978 | SH | SOLE | 52,978 | 0 | 0 | ||
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 8,422 | 54,785 | SH | SOLE | 54,785 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 443 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 117,244 | 403,955 | SH | SOLE | 403,955 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 13,239 | 140,538 | SH | SOLE | 140,538 | 0 | 0 | ||
bluebird bio, Inc. | Common | 09609G100 | 11,331 | 72,198 | SH | SOLE | 72,198 | 0 | 0 | ||
Blueprint Medicines Corporation | Common | 09627Y109 | 9,268 | 146,001 | SH | SOLE | 146,001 | 0 | 0 | ||
Boston Scientific Corporation | Common | 101137107 | 14,963 | 457,585 | SH | SOLE | 457,585 | 0 | 0 | ||
Bristol-Myers Squibb Company | Common | 110122108 | 36,028 | 651,030 | SH | SOLE | 651,030 | 0 | 0 | ||
Cardinal Health, Inc. | Common | 14149Y108 | 308 | 6,300 | SH | SOLE | 6,300 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 99,392 | 1,251,470 | SH | SOLE | 1,251,470 | 0 | 0 | ||
Celldex Therapeutics, Inc. | Common | 15117B103 | 53 | 105,800 | SH | SOLE | 105,800 | 0 | 0 | ||
Cellectis S.A. | Sponsored ADR | 15117K103 | 8,995 | 317,950 | SH | SOLE | 317,950 | 0 | 0 | ||
Centene Corporation | Common | 15135B101 | 22,772 | 184,819 | SH | SOLE | 184,819 | 0 | 0 | ||
Charles River Laboratories International, Inc. | Common | 159864107 | 2,545 | 22,670 | SH | SOLE | 22,670 | 0 | 0 | ||
Cidara Therapeutics, Inc. | Common | 171757107 | 826 | 158,784 | SH | SOLE | 158,784 | 0 | 0 | ||
Cigna Corporation | Common | 125509109 | 6,876 | 40,461 | SH | SOLE | 40,461 | 0 | 0 | ||
Clearside Biomedical, Inc. | Common | 185063104 | 884 | 82,665 | SH | SOLE | 82,665 | 0 | 0 | ||
Clovis Oncology, Inc. | Common | 189464100 | 3,428 | 75,400 | SH | SOLE | 75,400 | 0 | 0 | ||
Coherus Biosciences, Inc. | Common | 19249H103 | 3,372 | 240,843 | SH | SOLE | 240,843 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 677 | 203,935 | SH | SOLE | 203,935 | 0 | 0 | ||
CRISPR Therapeutics AG | Common | H17182108 | 10,480 | 178,348 | SH | SOLE | 178,348 | 0 | 0 | ||
CVS Health Corporation | Common | 126650100 | 23,586 | 366,521 | SH | SOLE | 366,521 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | Common | 23257D103 | 2,281 | 169,962 | SH | SOLE | 169,962 | 0 | 0 | ||
Danaher Corporation | Common | 235851102 | 19,033 | 192,871 | SH | SOLE | 192,871 | 0 | 0 | ||
Depomed, Inc. | Common | 249908104 | 420 | 62,973 | SH | SOLE | 62,973 | 0 | 0 | ||
Dermira, Inc. | Common | 24983L104 | 2,155 | 234,200 | SH | SOLE | 234,200 | 0 | 0 | ||
Diplomat Pharmacy, Inc. | Common | 25456K101 | 11,221 | 439,001 | SH | SOLE | 439,001 | 0 | 0 | ||
Editas Medicine, Inc. | Common | 28106W103 | 4,937 | 137,801 | SH | SOLE | 137,801 | 0 | 0 | ||
Edwards Lifesciences Corporation | Common | 28176E108 | 9,648 | 66,275 | SH | SOLE | 66,275 | 0 | 0 | ||
Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | 2,445 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
Eli Lilly and Company | Common | 532457108 | 33,288 | 390,108 | SH | SOLE | 390,108 | 0 | 0 | ||
Endo International plc | Shares | G30401106 | 10,169 | 1,078,414 | SH | SOLE | 1,078,414 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 6,576 | 485,325 | SH | SOLE | 485,325 | 0 | 0 | ||
Esperion Therapeutics, Inc. | Common | 29664W105 | 7,418 | 189,287 | SH | SOLE | 189,287 | 0 | 0 | ||
Evolent Health, Inc. | Class A | 30050B101 | 2,579 | 122,500 | SH | SOLE | 122,500 | 0 | 0 | ||
Exelixis, Inc. | Common | 30161Q104 | 9,211 | 428,022 | SH | SOLE | 428,022 | 0 | 0 | ||
Express Scripts Holding Company | Common | 30219G108 | 8,223 | 106,500 | SH | SOLE | 106,500 | 0 | 0 | ||
FibroGen, Inc. | Common | 31572Q808 | 11,156 | 178,207 | SH | SOLE | 178,207 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd. | Shares | M46135105 | 4,661 | 930,398 | SH | SOLE | 930,398 | 0 | 0 | ||
Galapagos NV | Sponsored ADR | 36315X101 | 8,003 | 86,815 | SH | SOLE | 86,815 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 146,192 | 2,063,699 | SH | SOLE | 2,063,699 | 0 | 0 | ||
GlaxoSmithKline plc | Shares | 37733W105 | 14,471 | 359,000 | SH | SOLE | 359,000 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | Common | 37890U108 | 2,684 | 59,390 | SH | SOLE | 59,390 | 0 | 0 | ||
Global Medical REIT Inc. | Common | 37954A204 | 650 | 73,400 | SH | SOLE | 73,400 | 0 | 0 | ||
GW Pharmaceuticals plc | ADS | 36197T103 | 9,977 | 71,497 | SH | SOLE | 71,497 | 0 | 0 | ||
HCA Healthcare, Inc. | Common | 40412C101 | 7,704 | 75,090 | SH | SOLE | 75,090 | 0 | 0 | ||
HCP, Inc. | Common | 40414L109 | 1,175 | 45,500 | SH | SOLE | 45,500 | 0 | 0 | ||
Healthcare Realty Trust Incorporated | Common | 421946104 | 1,977 | 68,000 | SH | SOLE | 68,000 | 0 | 0 | ||
Healthcare Trust of America, Inc. | Class A | 42225P501 | 1,240 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
Henry Schein, Inc. | Common | 806407102 | 2,281 | 31,400 | SH | SOLE | 31,400 | 0 | 0 | ||
Hologic, Inc. | Common | 436440101 | 777 | 19,546 | SH | SOLE | 19,546 | 0 | 0 | ||
Horizon Pharma plc | Shares | G4617B105 | 2,698 | 162,900 | SH | SOLE | 162,900 | 0 | 0 | ||
Humana Inc. | Common | 444859102 | 31,267 | 105,053 | SH | SOLE | 105,053 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 28,247 | 129,608 | SH | SOLE | 129,608 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 79,456 | 284,492 | SH | SOLE | 284,492 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 43,245 | 645,442 | SH | SOLE | 645,442 | 0 | 0 | ||
Innoviva, Inc. | Common | 45781M101 | 2,230 | 161,603 | SH | SOLE | 161,603 | 0 | 0 | ||
Intellia Therapeutics, Inc. | Common | 45826J105 | 4,580 | 167,381 | SH | SOLE | 167,381 | 0 | 0 | ||
Intuitive Surgical, Inc. | Common | 46120E602 | 11,234 | 23,479 | SH | SOLE | 23,479 | 0 | 0 | ||
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 3,452 | 82,838 | SH | SOLE | 82,838 | 0 | 0 | ||
Iovance Biotherapeutics, Inc. | Common | 462260100 | 427 | 33,395 | SH | SOLE | 33,395 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 19,031 | 110,452 | SH | SOLE | 110,452 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 108,367 | 893,082 | SH | SOLE | 893,082 | 0 | 0 | ||
Jounce Therapeutics, Inc. | Common | 481116101 | 78 | 10,127 | SH | SOLE | 10,127 | 0 | 0 | ||
LeMaitre Vascular, Inc. | Common | 525558201 | 909 | 27,150 | SH | SOLE | 27,150 | 0 | 0 | ||
LivaNova PLC | Common | G5509L101 | 628 | 6,287 | SH | SOLE | 6,287 | 0 | 0 | ||
Loxo Oncology, Inc. | Common | 548862101 | 1,798 | 10,365 | SH | SOLE | 10,365 | 0 | 0 | ||
LTC Properties, Inc. | Common | 502175102 | 8,961 | 209,673 | SH | SOLE | 209,673 | 0 | 0 | ||
Mallinckrodt plc | Shares | G5785G107 | 1,155 | 61,900 | SH | SOLE | 61,900 | 0 | 0 | ||
Masimo Corporation | Common | 574795100 | 4,689 | 48,020 | SH | SOLE | 48,020 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 13,180 | 98,797 | SH | SOLE | 98,797 | 0 | 0 | ||
Medical Properties Trust, Inc. | Common | 58463J304 | 12,055 | 858,586 | SH | SOLE | 858,586 | 0 | 0 | ||
The Medicines Company | Common | 584688105 | 8,762 | 238,741 | SH | SOLE | 238,741 | 0 | 0 | ||
Medtronic plc | Shares | G5960L103 | 36,272 | 423,693 | SH | SOLE | 423,693 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 77,940 | 1,284,022 | SH | SOLE | 1,284,022 | 0 | 0 | ||
Merus N.V. | Common | N5749R100 | 9,425 | 414,115 | SH | SOLE | 414,115 | 0 | 0 | ||
Molecular Templates, Inc. | Common | 608550109 | 754 | 144,110 | SH | SOLE | 144,110 | 0 | 0 | ||
Mylan N.V. | Shares | N59465109 | 59,885 | 1,657,017 | SH | SOLE | 1,657,017 | 0 | 0 | ||
NanoString Technologies, Inc. | Common | 63009R109 | 1,016 | 74,250 | SH | SOLE | 74,250 | 0 | 0 | ||
Nektar Therapeutics | Common | 640268108 | 9,218 | 188,769 | SH | SOLE | 188,769 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 26,502 | 269,769 | SH | SOLE | 269,769 | 0 | 0 | ||
Nevro Corp. | Common | 64157F103 | 4,231 | 52,990 | SH | SOLE | 52,990 | 0 | 0 | ||
New Senior Investment Group Inc. | Common | 648691103 | 4,004 | 528,919 | SH | SOLE | 528,919 | 0 | 0 | ||
NewLink Genetics Corporation | Common | 651511107 | 976 | 205,026 | SH | SOLE | 205,026 | 0 | 0 | ||
Novartis AG | Sponsored ADR | 66987V109 | 22,346 | 295,820 | SH | SOLE | 295,820 | 0 | 0 | ||
Novavax, Inc. | Common | 670002104 | 765 | 571,000 | SH | SOLE | 571,000 | 0 | 0 | ||
Novo Nordisk A/S | Sponsored ADR | 670100205 | 6,268 | 135,900 | SH | SOLE | 135,900 | 0 | 0 | ||
NuCana plc | Common | 67022C106 | 187 | 9,823 | SH | SOLE | 9,823 | 0 | 0 | ||
NuVasive, Inc. | Common | 670704105 | 1,021 | 19,580 | SH | SOLE | 19,580 | 0 | 0 | ||
Omega Healthcare Investors, Inc. | Common | 681936100 | 17,973 | 579,785 | SH | SOLE | 579,785 | 0 | 0 | ||
Ovid Therapeutics Inc. | Common | 690469101 | 4,179 | 535,824 | SH | SOLE | 535,824 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 2,720 | 37,300 | SH | SOLE | 37,300 | 0 | 0 | ||
Pfizer Inc. | Common | 717081103 | 85,609 | 2,359,687 | SH | SOLE | 2,359,687 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 6,233 | 391,016 | SH | SOLE | 391,016 | 0 | 0 | ||
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 10,583 | 2,087,380 | SH | SOLE | 2,087,380 | 0 | 0 | ||
Portola Pharmaceuticals, Inc. | Common | 737010108 | 3,398 | 89,978 | SH | SOLE | 89,978 | 0 | 0 | ||
PRA Health Sciences, Inc. | Common | 69354M108 | 3,030 | 32,460 | SH | SOLE | 32,460 | 0 | 0 | ||
Protagonist Therapeutics, Inc. | Common | 74366E102 | 1,472 | 219,042 | SH | SOLE | 219,042 | 0 | 0 | ||
Puma Biotechnology, Inc. | Common | 74587V107 | 4,930 | 83,340 | SH | SOLE | 83,340 | 0 | 0 | ||
Quorum Health Corporation | Common | 74909E106 | 119 | 23,725 | SH | SOLE | 23,725 | 0 | 0 | ||
Ra Pharmaceuticals, Inc. | Common | 74933V108 | 2,189 | 219,952 | SH | SOLE | 219,952 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 50,450 | 146,237 | SH | SOLE | 146,237 | 0 | 0 | ||
ResMed Inc. | Common | 761152107 | 6,073 | 58,630 | SH | SOLE | 58,630 | 0 | 0 | ||
Revance Therapeutics, Inc. | Common | 761330109 | 2,139 | 77,919 | SH | SOLE | 77,919 | 0 | 0 | ||
The RMR Group Inc. | Class A | 74967R106 | 584 | 7,441 | SH | SOLE | 7,441 | 0 | 0 | ||
Sabra Health Care REIT, Inc. | Common | 78573L106 | 15,746 | 724,606 | SH | SOLE | 724,606 | 0 | 0 | ||
Sage Therapeutics, Inc. | Common | 78667J108 | 22,480 | 143,614 | SH | SOLE | 143,614 | 0 | 0 | ||
Sangamo Therapeutics, Inc. | Common | 800677106 | 1,711 | 120,512 | SH | SOLE | 120,512 | 0 | 0 | ||
Sanofi | Common | 80105N105 | 7,198 | 179,900 | SH | SOLE | 179,900 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | Common | 803607100 | 30,995 | 234,489 | SH | SOLE | 234,489 | 0 | 0 | ||
Seattle Genetics, Inc. | Common | 812578102 | 18,550 | 279,417 | SH | SOLE | 279,417 | 0 | 0 | ||
Senior Housing Properties Trust | Shares | 81721M109 | 11,696 | 646,554 | SH | SOLE | 646,554 | 0 | 0 | ||
Shire plc | Shares | 82481R106 | 6,113 | 36,216 | SH | SOLE | 36,216 | 0 | 0 | ||
Smith & Nephew plc | Sponsored ADR | 83175M205 | 1,657 | 44,148 | SH | SOLE | 44,148 | 0 | 0 | ||
Spark Therapeutics, Inc. | Common | 84652J103 | 1,825 | 22,046 | SH | SOLE | 22,046 | 0 | 0 | ||
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 23,841 | 250,460 | SH | SOLE | 250,460 | 0 | 0 | ||
STERIS plc | Shares | G84720104 | 2,353 | 22,403 | SH | SOLE | 22,403 | 0 | 0 | ||
Stryker Corporation | Common | 863667101 | 23,072 | 136,631 | SH | SOLE | 136,631 | 0 | 0 | ||
Syndax Pharmaceuticals, Inc. | Common | 87164F105 | 1,404 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Teleflex Incorporated | Common | 879369106 | 1,711 | 6,379 | SH | SOLE | 6,379 | 0 | 0 | ||
Teligent, Inc. | Common | 87960W104 | 3,136 | 906,362 | SH | SOLE | 906,362 | 0 | 0 | ||
Tenet Healthcare Corporation | Common | 88033G407 | 5,522 | 164,500 | SH | SOLE | 164,500 | 0 | 0 | ||
TESARO, Inc. | Common | 881569107 | 4,223 | 94,970 | SH | SOLE | 94,970 | 0 | 0 | ||
Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | 3,068 | 859,322 | SH | SOLE | 859,322 | 0 | 0 | ||
Teva Pharmaceutical Industries Limited | Sponsored ADR | 881624209 | 26,359 | 1,083,843 | SH | SOLE | 1,083,843 | 0 | 0 | ||
TherapeuticsMD, Inc. | Common | 88338N107 | 1,463 | 234,384 | SH | SOLE | 234,384 | 0 | 0 | ||
Theravance Biopharma, Inc. | Common | G8807B106 | 183 | 8,083 | SH | SOLE | 8,083 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 31,629 | 152,695 | SH | SOLE | 152,695 | 0 | 0 | ||
Trillium Therapeutics Inc. | Common | 89620X506 | 2,810 | 468,399 | SH | SOLE | 468,399 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 5,916 | 76,958 | SH | SOLE | 76,958 | 0 | 0 | ||
uniQure N.V. | Shares | N90064101 | 1,427 | 37,741 | SH | SOLE | 37,741 | 0 | 0 | ||
United Therapeutics Corporation | Class B | 91307C102 | 4,669 | 41,261 | SH | SOLE | 41,261 | 0 | 0 | ||
Unitedhealth Group Incorporated | Common | 91324P102 | 104,347 | 425,317 | SH | SOLE | 425,317 | 0 | 0 | ||
Varian Medical Systems, Inc. | Common | 92220P105 | 2,983 | 26,227 | SH | SOLE | 26,227 | 0 | 0 | ||
Ventas, Inc. | Common | 92276F100 | 5,609 | 98,496 | SH | SOLE | 98,496 | 0 | 0 | ||
Verona Pharma plc | Sponsored ADR | 925050106 | 3,781 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 98,835 | 581,522 | SH | SOLE | 581,522 | 0 | 0 | ||
Welltower Inc. | 6.50% Preferred Perpetual | 95040Q203 | 11,890 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Welltower Inc. | Common | 95040Q104 | 2,856 | 45,560 | SH | SOLE | 45,560 | 0 | 0 | ||
Wright Medical Group N.V. | Ordinary Shares | N96617118 | 6,926 | 266,781 | SH | SOLE | 266,781 | 0 | 0 | ||
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 1,507 | 163,819 | SH | SOLE | 163,819 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 13,244 | 118,846 | SH | SOLE | 118,846 | 0 | 0 | ||
Zoetis, Inc. | Class A | 98978V103 | 3,046 | 35,760 | SH | SOLE | 35,760 | 0 | 0 | ||
Zogenix, Inc. | Common | 98978L204 | 1,563 | 35,352 | SH | SOLE | 35,352 | 0 | 0 |